Table 1 General demographic data and scale evaluation analysis in the patient and control group.
Item | Patient group (N = 46) | Control group (N = 43) | χ2/Z/t | P |
|---|---|---|---|---|
Age (years) | 46.00 (38.75, 52.00) | 38.00 (30.00, 51.00) | − 1.914 | 0.056 |
BMI (kg/m2) | 24.33 ± 3.85 | 23.98 ± 3.69 | 0.438 | 0.662 |
Sex | 2.448 | 0.118 | ||
Male | 33 (71.7) | 24 (55.8) | ||
Female | 13 (28.3) | 19 (44.2) | ||
Duration of illness (years) | 20.52 ± 10.55 | – | ||
Chlorpromazine equivalent (mg) | 500.00 (393.75, 741.50) | – | ||
The total score of PANSS | 49.50 (43.00, 56.00) | – | ||
The possitive score of PANSS | 7.00 (7.00, 11.00) | – | ||
The negative score of PANSS | 18.00 (14.75, 22.00) | – | ||
The general pathological score of PANSS | 23.00 (20.00, 27.25) | – | ||
The total score of SSPI | 23.35 ± 7.41 | – | ||
The score of SSPI factor I | 9.00 (8.00, 9.00) | – | ||
The score of SSPI factor II | 8.46 ± 4.10 | – | ||
The score of SSPI factor III | 6.30 ± 3.29 | – | ||
Physical functioning of SF-36 | – | 100.00 (100.00, 100.00) | ||
Role-physical of SF-36 | – | 100.00 (100.00, 100.00) | ||
Body pain of SF-36 | – | 100.00 (84.00, 100.00) | ||
General health of SF-36 | – | 82.00 (70.00, 97.00) | ||
Vitality of SF-36 | – | 80.00 (70.00, 85.00) | ||
Social functioning of SF-36 | – | 112.50 (100.00, 112.50) | ||
Role-emotional of SF-36 | – | 100.00 (100.00, 100.00) | ||
Mental health of SF-36 | – | 73.86 ± 13.95 | ||
Total body health of SF-36 | – | 95.25 (87.25, 98.00) | ||
Total mental health of SF-36 | – | 89.38 (79.13, 95.63) | ||
Total score of SF-36 | – | 91.19 (86.00, 95.44) |
